Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer

SIMPLE SUMMARY: Among all types of cancer, Pancreatic Ductal Adenocarcinoma (PDAC) has one of the lowest survival rates, partly due to the failure of current chemotherapeutics. This treatment failure can be attributed to the complicated nature of the tumor microenvironment, where the rich fibro-infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Haque, Muhammad R., Rempert, Trevor H., Al-Hilal, Taslim A., Wang, Chengyao, Bhushan, Abhinav, Bishehsari, Faraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430573/
https://www.ncbi.nlm.nih.gov/pubmed/34503294
http://dx.doi.org/10.3390/cancers13174487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430573/
https://www.ncbi.nlm.nih.gov/pubmed/34503294
http://dx.doi.org/10.3390/cancers13174487

Ejemplares similares